Organoids study finds potential new treatment for pulmonary neuroendocrine tumors
Researchers from the Organoid Group and the Rare Cancers Genomics Team have created a new model for studying neuroendocrine tumors (NETs) in the lab. The researchers found that some types of NETs need the protein Epidermal Growth Factor (EGF) to grow, potentially making them treatable with inhibitors of the EGF receptor. This discovery is surprising…